BCRX

BioCryst Pharmaceuticals, Inc. $8.23 1M -16.1% 3M -5.4% YTD +9.7% as of 2026-09-14
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.1%
Next 1 week
-0.4%
Next 1 month
-0.8%
Seasonality
Weak window historically
Next 30 days (to Oct 15): -5.0% median, 26% of the last 31 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 27
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.06%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.61 -0.3% · Seasonal tilt -0.5%
$32M/day volume 49% volatility +2% 1-year -78% from ATH
52-week range · 43% of the way up · -27% from the high
$6.00$11.22

Congressional trades in BCRX Full tracker →

2 members · 4 buys / 1 sells · $5K–$75K disclosed · latest filing Sep 4, 2026.

BUY GC Gilbert Cisneros · traded Jul 10, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Nov 13, 2025 $1K–$15K
BUY JG Josh Gottheimer · traded Oct 16, 2023 $1K–$15K
SELL JG Josh Gottheimer · traded Sep 15, 2023 $1K–$15K
BUY JG Josh Gottheimer · traded Aug 11, 2022 $1K–$15K

Earnings Full history →

Next report 2026-11-02 (Monday, before open, in 48 days) · EPS est. 0.12.

1-day std dev
11.1%
Finished up
42%
Biggest pop
+23.5%
Biggest drop
-40.4%

Standard deviation of the close-to-close move over the last 60 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.